These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8901071)

  • 1. Age-related changes in valproic acid binding to rat serum proteins in vitro.
    Slattum PW; Cato AE; Pollack GM; Brouwer KL
    J Pharm Sci; 1996 Apr; 85(4):373-6. PubMed ID: 8901071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender- or age-related binding characteristics of valproic acid to serum proteins in adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yukawa E; Fujimura A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):57-63. PubMed ID: 11438424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and protein binding of valproic acid in the developing rat.
    Haberer LJ; Pollack GM
    Drug Metab Dispos; 1994; 22(1):113-9. PubMed ID: 8149869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of altered drug binding to serum proteins in pregnant women: studies with valproic acid.
    Riva R; Albani F; Contin M; Baruzzi A; Altomare M; Merlini GP; Perucca E
    Ther Drug Monit; 1984; 6(1):25-30. PubMed ID: 6424276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic interaction between valproic acid and free fatty acids in rhesus monkeys.
    Johno I; Huang MY; Levy RH
    Epilepsia; 1982 Dec; 23(6):649-56. PubMed ID: 6816579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear binding of valproic acid (VPA) and E-delta 2-valproic acid to rat plasma proteins.
    Semmes RL; Shen DD
    Pharm Res; 1990 May; 7(5):461-7. PubMed ID: 2114617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein binding of valproic acid in the presence of elevated free fatty acids in patient and normal human serum.
    Zimmerman CL; Patel IH; Levy RH; Edwards D; Nelson SD; Hutchinson M
    Epilepsia; 1981 Feb; 22(1):11-7. PubMed ID: 6781885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal oscillations in plasma protein binding of valproic acid.
    Patel IH; Venkataramanan R; Levy RH; Viswanathan CT; Ojemann LM
    Epilepsia; 1982 Jun; 23(3):283-90. PubMed ID: 6806086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):845-56. PubMed ID: 10859159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein binding of valproic acid in healthy subjects and in patients with liver disease.
    Urien S; Albengres E; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):319-25. PubMed ID: 6790449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture.
    Lewandowski C; Klug S; Nau H; Neubert D
    Arch Toxicol; 1986 Apr; 58(4):239-42. PubMed ID: 3087328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites.
    Nau H; Helge H; Luck W
    J Pediatr; 1984 Apr; 104(4):627-34. PubMed ID: 6423793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valproate on the pharmacokinetics of free and total plasma bilirubin in experimental hyperbilirubinemia in guinea pigs.
    Yu HY; Shen YZ
    J Pharm Sci; 1998 Jan; 87(1):21-4. PubMed ID: 9452963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of valproic acid disposition and metabolism: a developmental study in postnatal lambs and adult sheep.
    Wong H; Kumar S; Rurak DW; Kwan E; Abbott FS; Riggs KW
    Drug Metab Dispos; 2000 Aug; 28(8):912-9. PubMed ID: 10901700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of gender or age on binding characteristics of valproic acid to serum proteins in pediatric patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Fujimura A
    J Clin Pharmacol; 1999 Oct; 39(10):1070-6. PubMed ID: 10516942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas--liquid chromatography: methodological aspects and observations in epileptic patients.
    Riva R; Albani F; Baruzzi A; Galvani I; Perucca E
    Ther Drug Monit; 1982; 4(4):341-52. PubMed ID: 6818733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent pharmacokinetics and metabolism of valproic acid in newborn lambs and adult sheep.
    Wong H; Rurak DW; Kumar S; Kwan E; Abbott FS; Riggs KW
    Drug Metab Dispos; 2001 May; 29(5):664-75. PubMed ID: 11302932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saturable transport of valproic acid in rat choroid plexus in vitro.
    Naora K; Ichikawa N; Nishimura N; Hirano H; Shen DD; Iwamoto K
    J Pharm Sci; 1996 Apr; 85(4):423-6. PubMed ID: 8901082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.
    Albani F; Riva R; Procaccianti G; Baruzzi A; Perucca E
    Epilepsia; 1983 Feb; 24(1):65-73. PubMed ID: 6401631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo determination of valproate binding constants during sole and multi-drug therapy.
    Scheyer RD; Cramer JA; Toftness BR; Hochholzer JM; Mattson RH
    Ther Drug Monit; 1990 Mar; 12(2):117-23. PubMed ID: 2107606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.